Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa

Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen

(2018) Tim Rollenske et al.   NATURE IMMUNOLOGY

The role of vaccines in preventing bacterial antimicrobial resistance

(2018) Kathrin U Jansen et al.   NATURE MEDICINE

The antibiotic pipeline: reviving research and development and speeding drugs to market

(2017) Katherine H. Luepke et al.   Expert Review of Anti-Infective Therapy

Polysaccharide conjugate vaccine protein carriers as a “neglected valency” – Potential and limitations

(2017) Michael Bröker et al.   VACCINE

Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae

(2017) Meghan E. Pennini et al.   Nature Communications

Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa

(2017) Scott M. Baliban et al.   PLoS Neglected Tropical Diseases

Comparison of the Microbiota of Older Adults Living in Nursing Homes and the Community

(2017) Mary-Claire Roghmann et al.   mSphere

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?

(2016) Marc Lipsitch et al.   mBio

Molecular Epidemiology of Colonizing and Infecting Isolates of Klebsiella pneumoniae

(2016) Rebekah M. Martin et al.   mSphere

Rapid and Accurate Determination of Lipopolysaccharide O-Antigen Types in Klebsiella pneumoniae with a Novel PCR-Based O-Genotyping Method

(2015) Chi-Tai Fang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multistate Point-Prevalence Survey of Health Care–Associated Infections

(2014) Shelley S. Magill et al.   NEW ENGLAND JOURNAL OF MEDICINE

A scalable method for biochemical purification of Salmonella flagellin

(2014) Raphael Simon et al.   PROTEIN EXPRESSION AND PURIFICATION

wzi Gene Sequencing, a Rapid Method for Determination of Capsular Type for Klebsiella Strains

(2013) S. Brisse et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Capsular Types of Klebsiella pneumoniae Revisited by wzc Sequencing

(2013) Yi-Jiun Pan et al.   PLoS One

Hypervirulent (hypermucoviscous)Klebsiella pneumoniae

(2013) Alyssa S. Shon et al.   Virulence

Lipopolysaccharide O1 Antigen Contributes to the Virulence in Klebsiella pneumoniae Causing Pyogenic Liver Abscess

(2012) Pei-Fang Hsieh et al.   PLoS One

Efficacy of a Conjugate Vaccine Containing Polymannuronic Acid and Flagellin against Experimental Pseudomonas aeruginosa Lung Infection in Mice

(2011) Victoria L. Campodónico et al.   INFECTION AND IMMUNITY

Engineering and Preclinical Evaluation of Attenuated Nontyphoidal Salmonella Strains Serving as Live Oral Vaccines and as Reagent Strains

(2011) Sharon M. Tennant et al.   INFECTION AND IMMUNITY

Salmonella enterica Serovar Enteritidis Core O Polysaccharide Conjugated to H:g,m Flagellin as a Candidate Vaccine for Protection against Invasive Infection withS.Enteritidis

(2011) Raphael Simon et al.   INFECTION AND IMMUNITY

Comparative effects of carrier proteins on vaccine-induced immune response

(2011) Markus Knuf et al.   VACCINE

Development of immunization trials against Klebsiella pneumoniae

(2011) Tarek A. Ahmad et al.   VACCINE

PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets

(2010) J. F. Turton et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Carbohydrate vaccines: developing sweet solutions to sticky situations?

(2010) Rena D. Astronomo et al.   NATURE REVIEWS DRUG DISCOVERY

Glycoconjugate vaccines and immune interference: A review

(2010) Ron Dagan et al.   VACCINE

Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines

(2009) V. L. Campodonico et al.   INFECTION AND IMMUNITY

Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections

(2008) Abigail Clements et al.   VACCINE

Vaccines and immunotherapy against Pseudomonas aeruginosa

(2008) Gerd Döring et al.   VACCINE